Steven M Shapiro
Overview
Explore the profile of Steven M Shapiro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
736
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaplan M, Hammerman C, Shapiro S
J Pediatr
. 2023 Nov;
265:113810.
PMID: 37913902
No abstract available.
2.
Gelineau-Morel R, Usman F, Shehu S, Yeh H, Suwaid M, Abdulsalam M, et al.
Pediatr Res
. 2023 Sep;
95(1):285-292.
PMID: 37689774
Background: Kernicterus spectrum disorder (KSD) resulting from neonatal hyperbilirubinemia remains a common cause of cerebral palsy worldwide. This 12-month prospective cohort study followed neonates with hyperbilirubinemia to determine which clinical...
3.
Holzapfel L, Arnold C, Tyson J, Shapiro S, Reynolds E, Pedroza C, et al.
BMC Pediatr
. 2023 Jul;
23(1):347.
PMID: 37430233
Background: Bilirubin neurotoxicity (BN) occurs in premature infants at lower total serum bilirubin levels than term infants and causes neurodevelopmental impairment. Usual dose lipid infusions in preterm infants may increase...
4.
Kaplan M, Hammerman C, Shapiro S
J Pediatr
. 2023 May;
261:113452.
PMID: 37169338
No abstract available.
5.
Yang F, Vivian J, Traxler C, Shapiro S, Stanford J
Cell Transplant
. 2022 May;
31:9636897221101116.
PMID: 35596532
Kernicterus is a permanent condition caused by brain damage from bilirubin toxicity. Dystonia is one of the most debilitating symptoms of kernicterus and results from damage to the globus pallidus...
6.
Dasari V, Shapiro S, Yeh H, Gelineau-Morel R
Pediatr Res
. 2021 Nov;
91(4):862-866.
PMID: 34741107
Background: Kernicterus Spectrum Disorders (KSDs) result from hyperbilirubinemia-induced brain injury. We developed a Toolkit (KSD-TK) to predict the likelihood of KSDs. This study aims to validate the KSD-TK by comparing...
7.
Welleford A, Quintero J, El Seblani N, Blalock E, Gunewardena S, Shapiro S, et al.
Cell Transplant
. 2020 May;
29:963689720926157.
PMID: 32425114
The development of regenerative therapies for central nervous system diseases can likely benefit from an understanding of the peripheral nervous system repair process, particularly in identifying potential gene pathways involved...
8.
Riordan S, Shapiro S
Pediatr Res
. 2019 Oct;
87(2):327-331.
PMID: 31600770
Despite the availability of successful prevention strategies to prevent excessive hyperbilirubinemia, the neurological sequelae of bilirubin neurotoxicity (BNTx) still occur throughout the world. Kernicterus, encephalopathy due to BNTx, is now...
9.
Shapiro S, Riordan S
Pediatr Res
. 2019 Oct;
87(2):332-337.
PMID: 31581172
Previously in Part I of this two-part review, we discussed the current and recent advances in the understanding of the molecular biology and neuropathology of bilirubin neurotoxicity (BNTx). Here in...
10.
Yang F, Draper J, Smith P, Vivian J, Shapiro S, Stanford J
Cell Transplant
. 2018 May;
27(4):654-665.
PMID: 29845869
Neonatal hyperbilirubinemia targets specific brain regions and can lead to kernicterus. One of the most debilitating symptoms of kernicterus is dystonia, which results from bilirubin toxicity to the globus pallidus...